Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate. [electronic resource]
Producer: 20060814Description: 3760-5 p. digitalISSN:- 1007-9327
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Benzamides
- Exons -- genetics
- Female
- Gastrointestinal Stromal Tumors -- drug therapy
- Gene Expression Regulation, Neoplastic
- Humans
- Imatinib Mesylate
- Intestinal Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Piperazines -- adverse effects
- Platelet-Derived Growth Factor -- genetics
- Prognosis
- Prospective Studies
- Proto-Oncogene Proteins c-kit -- genetics
- Pyrimidines -- adverse effects
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.